丙型肝炎病毒抗体依赖性增强作用的研究现状及意义

高禄化; 聂青和

丙型肝炎病毒抗体依赖性增强作用的研究现状及意义

第四军医大学唐都医院传染病科

基金项目:

国家自然科学基金资助项目(No:30771891)；

详细信息

中图分类号: R512.63
计量
- 文章访问数: 369
- HTML全文浏览量: 21
- PDF下载量: 126
- 被引次数: 0
出版历程
- 出版日期: 2011-08-20

The present research situation and significance of HCV ADE

Research funding:

摘要

摘要: 抗体协助病毒进入靶细胞,提高感染率,这一现象称为抗体依赖性增强作用(ADE)。ADE一方面保护免疫的诱导作用,另一方面增强敏感性的诱导作用,它们之间存在微妙的平衡关系。人们发现在多种病毒感染中广泛存在ADE效应,且常规疫苗预防及治疗此类病毒感染难以奏效。因此,近年来ADE越来越受到人们的重视。本文着重阐述ADE效应在丙型肝炎病毒(HCV)中的作用机制,旨为HCV发病机理及慢性丙型肝炎治疗、HCV疫苗研发提供新思路。
- 肝炎病毒属 /
- 受体,Fc /
- 受体,补体
Abstract: Antibody-dependent enhancement (ADE) is a phenomenon in the process of virus infection which refers to the virus-specific antibodies which can help or facilitate virus to enter the target cells.These antibodies have double effects, which are balanced between protection effects or enhancement effects of infection according to different antibody concentration.ADE is observed in many virus infection processes, moreover, the conventional vaccine usually has no effect to prevent or treat them.In this review, we discuss the mechanism of ADE in HCV infection, aiming to provide some new thoughts for HCV pathogenesis study, therapy and vaccine research.
- hepacivirus /
- receptors /
- Fc

HTML全文

参考文献(20)

[1]Hawkes RA.Enhancement of the infectivity of arboviruses by spe-cific antisera produced in domestic fowls[J].Aust J Exp Biol MedSci, 1964, 42:465-482.

[2]Tirado, SM, Yoon KJ.Antibody-dependent enhancement of virusinfection and disease[J].Viral Immunol, 2003, 16 (1) :69-86.

[3]Mori S, Takeuchi T, Kanda T.Antibody-enhancement of adeno-associated virus infection of human monocytic cell lines[J].Virolo-gy, 2008, 375 (1) :141-147.

[4]Halstead SB, Shotwell H, Casals J.Studies on the pathogenesis ofdengue infection in monkeys.Ⅱ.Clinical laboratory responses toheterologous infection[J].Infect Dis, 1973, 128 (1) :15-22.

[5]Lavillette D, Morice Y, Germanidis G.Human serum facilitateshepatitis C virus infection, and neutralizing responses inversely cor-relate with viral replication kinetics at the acute phase of hepatitis Cvirus infection[J].Virol, 2005, 79 (10) :6023-6034.

[6]Meunier JC, Engle RE, Faulk K, et al.Evidence for cross-geno-type neutralization of hepatitis C virus pseudo-particles and en-hancement of infectivity by apolipoprotein C1[J].Proc Natl AcadSci USA, 2005, 102 (12) :4560-4565.

[7]Munakata Y, Kato I, Saito T, et al.Human parvovirus B19 infec-tion of monocytic cell line U937 and antibody-dependent enhance-ment[J].Virology, 2006, 345 (1) :251-257.

[8]Huanq KJ, Yang YC, Lin YS, et al.The dual-special binding ofdengue virus and target cells for the antibody dependent enhance-ment of dengue virus infection[J].Immunl, 2006, 176 (5) :2825-2832.

[9]Takada A, Kawaoka Y.Antibody-dependent enhancement of viralinfection:molecular mechanisms and in vivo implications[J].RevMed Virol, 2003, 13 (6) :387-98.

[10]Burton DR, Saphire EQ, Parren PW.A model for neutralizationofviruses based on antibody coating of the virion surface[J].Curr TopMicrobiol Immunol, 2001, 60 (2) :109-143.

[11]Mori S, Takeuchi T, Kanda T.Antibody-enhancement of adeno-associated virus infection of human monocytic cell lines[J].Virolo-gy, 2008, 375 (1) :141-147.

[12]Bartosch B, Dubuisson J, Cosset FL.Infectious hepatitis C viruspseudo-particles containing functional E1-E2 envelope proteincomplexes[J].Exp Med, 2003, 197 (5) :633-642.

[13]Basu A, Kanda T, Beyene A, et al.Sulfated homologues of heparininhibit hepatitis C virus entry into mammalian cells[J].Virol, 2007, 81 (8) :3933-3941.

[14]Hadlock KG, Lanford RE, Perkins S, et al.Human monoclonal an-tibodies that inhibit binding of hepatitis C virus E2 protein to CD81and recognize conserved conformational epitopes[J].Virol, 2000, 74 (22) :10407-10416.

[15]Kanda T, Basu A, Steele R, Generation of infectious hepatitis C vi-rus in immortalized human hepatocytes[J].Virol, 2006, 80 (9) :4633-4639.

[16]Cao J, Chen ZH, Ren YL, et al.Oral immunization with attenuatedSalmonella carrying a co-expression plasmid encoding the core andE2 proteins of hepatitis C virus capable of inducing cellular immuneresponses and neutralizing antibodies in mice[J].Vaccine, 2011, 29 (20) :3714-3723.

[17]Toth FD, Mosborg-Petersen P, Kiss J, et al.Antibody-depend-ent enhancement of HIV-1 infection in human term syncytiotropho-blast cells cultured in vitro[J].Clin Exp Immunol.1994, 96 (3) :389-394.

[18]聂青和, 罗新栋, 张亚飞, 等.HCV感染人滋养层细胞过程中抗体依赖性增强作用的初步研究[J].胃肠病学和肝病学杂志, 2006, 15 (4) :379-382.

[19]Meyer K, Ait-Goughoulte M, Keck ZY, et al.Antibody-de-pendent enhancement of hepatitis C virus infection[J].J Virol, 2008, 82 (5) :2140-2149.

[20]Nicholson CO, Costin JM, Rowe DK, et al.Viral entry inhibitorsblock dengue antibody-dependent enhancement in vitro[J].Anti-viral Research, 2011, 89 (1) :71-74.

施引文献

资源附件(0)

访问统计